Genetic determinants for activated fluoropyrimidine chemotherapy.
- Published in:
- Drug Development Research, 2006, v. 67, n. 2, p. 119, doi. 10.1002/ddr.20090
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2006 AND VI 67 AND IP 2
Results: 6
1
2
Analysis of active site loop amino acids of lactate dehydrogenase from Plasmodium vivax by site‐directed mutagenesis studies.
- Published in:
- Drug Development Research, 2006, v. 67, n. 2, p. 175, doi. 10.1002/ddr.20089
- By:
- Publication type:
- Article
3
Design and implementation of an activity‐based costing system in a pharmaceutical drug discovery environment.
- Published in:
- Drug Development Research, 2006, v. 67, n. 2, p. 107, doi. 10.1002/ddr.20088
- By:
- Publication type:
- Article
4
Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer.
- Published in:
- Drug Development Research, 2006, v. 67, n. 2, p. 166, doi. 10.1002/ddr.20087
- By:
- Publication type:
- Article
5
Heme oxygenase‐1: a new drug target in oxidative tissue injuries in critically ill conditionsThis study was in part supported by grants from Grant‐in‐Aid for Scientific Research (08877240, 09671564, 10671416, 11671499, 12877246, 13671582, 14571440, 15591916, 15659427, 16591542 and 17591888) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
- Published in:
- Drug Development Research, 2006, v. 67, n. 2, p. 130, doi. 10.1002/ddr.20073
- By:
- Publication type:
- Article
6
Pharmacokinetic evaluation and studies on the clinical efficacy of guar gum‐–based oral drug delivery systems of albendazole and albendazole‐β‐cyclodextrin for colon‐targeting in human volunteers.
- Published in:
- Drug Development Research, 2006, v. 67, n. 2, p. 154, doi. 10.1002/ddr.20072
- By:
- Publication type:
- Article